Justin C. Roth

Affiliations: 
Hematology/Oncology Case Western Reserve University School of Medicine, Cleveland, OH, United States 
Google:
"Justin Roth"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ghonime MG, Saini U, Kelly MC, et al. (2021) Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy. Journal For Immunotherapy of Cancer. 9
Ghonime MG, Roth JC, Barker NJ, et al. (2020) Abstract A15: Improving immune recognition of shared tumor-associated antigens in pediatric tumors using a multimodal oncolytic virus Cancer Research. 80
Cassady K, Miller K, Prasad N, et al. (2019) ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL Neuro-Oncology. 21: vi8-vi8
Ghonime MG, Jackson J, Shah A, et al. (2017) Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory. Translational Oncology. 11: 86-93
Cassady KA, Bauer DF, Roth J, et al. (2017) Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates. Molecular Therapy Oncolytics. 5: 1-10
Roth JC, Alberti MO, Ismail M, et al. (2015) MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors. Virus Research. 196: 170-80
Jackson JD, McMorris AM, Roth JC, et al. (2014) Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Therapy. 21: 984-90
Smith TT, Roth JC, Friedman GK, et al. (2014) Oncolytic viral therapy: targeting cancer stem cells. Oncolytic Virotherapy. 2014: 21-33
Gaston DC, Odom CI, Li L, et al. (2013) Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1. Plos One. 8: e81768
Sawant A, Schafer CC, Jin TH, et al. (2013) Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways. Cancer Research. 73: 6609-20
See more...